Compare Nasdaq Inc (NDAQ) vs Veritone Inc (VERI) Price & Performance

Nasdaq Inc. (NDAQ) trades at $93.65, up 1.87% on the day, reflecting strong momentum. The stock exhibits a bullish technical signal with moving averages supporting further upside, while recent earnings beats and a 22.52% net income margin highlight robust profitability. Positive news includes the addition of Moderna to the Nasdaq-100 Index and HSBC adopting Nasdaq's Calypso platform, signaling business growth.

Outlook remains favorable with a consensus price target of $110.43, implying 18% upside. Key risks include cash flow volatility and high debt levels, but analyst sentiment is strongly bullish with 61% buy ratings. Revenue growth and AI-driven platform adoption present opportunities, though market volatility and competitive pressures warrant monitoring.

Veritone (VERI) trades at $0.5647, down 18.31% over 24 hours, reflecting significant bearish pressure. The stock shows mixed signals with a bearish technical outlook but bullish oscillators. Fundamentally, the company reported a net loss of $111.73M in 2025 with a negative net income margin of -117.54%, though revenue remains near $92M. Recent developments include a $15M equity offering and partnerships with ATP Media and ZeroEyes, indicating ongoing business development efforts amidst financial challenges.

The outlook for VERI is highly speculative, with a consensus analyst price target of $3.75 suggesting substantial upside potential from current levels. However, persistent losses, negative cash flow from operations, and ongoing securities litigation pose significant risks. Investment appeal hinges on the company's ability to achieve profitability and monetize its AI solutions, making it suitable only for risk-tolerant investors.